Spirochetal uveitis: Spectrum of clinical manifestations, diagnostic and therapeutic approach, final outcome and epidemiological data

Int Ophthalmol. 2021 Dec;41(12):4111-4126. doi: 10.1007/s10792-021-01984-x. Epub 2021 Jul 23.

Abstract

Purpose: Analysis of cases with spirochetal uveitis related to spirochetes in a tertiary referral academic center.

Methods: Retrospective study of patients diagnosed with uveitis attributed to Treponema pallidum, Leptospira spp. and Borrelia burgdorferi from June 1991 until December 2019.

Results: A total of 57 cases of spirochetal uveitis (22 patients with T. pallidum, 26 with Leptospira spp., and 9 with B. burgdorferi) that consisted 1% of the overall number of uveitics were recorded. All these cases presented with a wide spectrum of clinical presentations (anterior uveitis, posterior uveitis, panuveitis, vasculitis, papillitis, and in some rare cases concomitant posterior scleritis). The treatment included mainly penicillin or doxycycline, while corticosteroids were administered systematically in some cases with Borrelia or Leptospira infection. The final visual outcome was favorable (> 6/10 in Snellen visual acuity) in approximately 76% of our patients.

Conclusion: Despite being rare, spirochetal uveitis can be detrimental for the vision and must always be included in the differential diagnosis.

Keywords: Borrelia; Infectious uveitis; Leptospira; Spirochetes; Syphilis.

MeSH terms

  • Humans
  • Retrospective Studies
  • Scleritis*
  • Spirochaetales
  • Syphilis*
  • Uveitis* / diagnosis
  • Uveitis* / drug therapy
  • Uveitis* / epidemiology